It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The ability of serum biomarkers to predict the prognosis and response to deep-brain stimulation (DBS) therapy in Parkinson’s disease (PD) patients is promising. Here, we showed that NfL differed between healthy individuals and PD patients and that changes in NfL, GFAP, and BDNF occurred only transiently after DBS surgery. Therefore, subthalamic stimulation does not promote neurodegeneration, and these biomarkers do not serve as clinical improvement endpoints in PD DBS patients.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Institute of Biomedical Research Cadiz (INiBICA), Cadiz, Spain; University of Cadiz, Cadiz, Spain (GRID:grid.7759.c) (ISNI:0000 0001 0358 0096)
2 Institute of Biomedical Research Cadiz (INiBICA), Cadiz, Spain (GRID:grid.7759.c)
3 Institute of Biomedical Research Cadiz (INiBICA), Cadiz, Spain (GRID:grid.7759.c); Puerta del Mar University Hospital, Neurology Department, Cadiz, Spain (GRID:grid.411342.1) (ISNI:0000 0004 1771 1175)
4 Institute of Biomedical Research Cadiz (INiBICA), Cadiz, Spain (GRID:grid.411342.1); University of Cadiz, Cadiz, Spain (GRID:grid.7759.c) (ISNI:0000 0001 0358 0096)
5 Institute of Biomedical Research Cadiz (INiBICA), Cadiz, Spain (GRID:grid.7759.c); University of Cadiz, Cadiz, Spain (GRID:grid.7759.c) (ISNI:0000 0001 0358 0096)
6 Institute of Biomedical Research Cadiz (INiBICA), Cadiz, Spain (GRID:grid.7759.c); Puerta del Mar University Hospital, Neurosurgery Department, Cadiz, Spain (GRID:grid.411342.1) (ISNI:0000 0004 1771 1175)
7 Institute of Bio-Health Research (IBS. Granada), Department of Neurology, Virgen de las Nieves University Hospital, Granada, Spain (GRID:grid.507088.2)
8 Institute of Biomedical Research Cadiz (INiBICA), Cadiz, Spain (GRID:grid.507088.2); Puerta del Mar University Hospital, Neurology Department, Cadiz, Spain (GRID:grid.411342.1) (ISNI:0000 0004 1771 1175)